Revolutions Medical (RMCP) 0.0074 $RMCP
Safety Syringes Market - Global Industry Analysis Forecasts to 2019
M2 - Thu Aug 28, 5:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2rsq89/safety_syringes) has announced the addition of the "Safety Syringes Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global market for safety syringes was valued at USD 3,419.1 million in 2012 and is expected to reach USD 6,496.8 million by the end of 2019, growing at a CAGR of 9.7% during the forecast period from 2013 to 2019 Two major types of safety syringes available in the market consist of retractable safety syringes and non-retractable-safety syringes. In 2012, non-retractable safety syringes that include sheathing tube syringes, syringes with sliding needle covers and hinged needle covers accounted for the larger share in terms of revenue (USD Million) as well as volume (Million Units). However, during the forecast period, the market for retractable safety syringes is expected to grow at a higher CAGR than the non-retractable safety syringes due to increasing safety concerns and adoption in developed regions. The market for retractable safety syringes has been further segmented as automatic retractable safety syringes and manual retractable safety syringes. Automatic retractable safety syringes are more preferred than manual retractable syringes owing to advantage such as ease of use and enhanced safety. The global market for safety syringes is primarily driven by factors such as increasing cases of needlestick injuries and their serious consequences, governmental legislation, overall growth in injectable drugs market and technical advances leading to syringes with improved safety features. According to the U.S. Occupational Safety and Health Administration (OSHA), approximately 5.6 million healthcare workers across the U.S. are high risk of exposure to blood borne diseases via needlestick and other sharp related injuries. The above mentioned fact indicates a favorable growth for safety syringes market. However, the market may face significant challenges from higher cost associated with the safety syringes and continuous development in alternative drug delivery methods. Safety syringes cost two to three times more than the traditional syringes that results in slow adoption rate of safety syringes across the healthcare facilities. This factor is more prominent across the developing nations where healthcare providers believe that the incidence of needlestick injuries can be prevented by providing training to healthcare workers and thus, avoids spending money on purchasing safety syringes. Safety Syringes Market, by Product Type - Retractable Safety Syringes - Automatic Retractable Safety Syringes - Manual Retractable Safety Syringes - Non Retractable Safety Syringes Company Profiles - Becton, Dickinson & Company - Covidien plc - Retractable Technologies, Inc. - Revolutions Medical Corporation - Smiths Medical - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/2r...y_syringes
Global Safety Syringes Market 2013-2019: Retractable, Automatic Retractable, Manual Retractable Non-Retractable Safety Syringes
M2 - Tue Jul 22, 2:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d73f6p/safety_syringes) has announced the addition of the "Safety Syringes - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013" report to their offering. The global market for safety syringes was valued at USD 3,419.1 million in 2012 and is expected to reach USD 6,496.8 million by the end of 2019, growing at a CAGR of 9.7% during the forecast period from 2013 to 2019. Two major types of safety syringes available in the market consist of retractable safety syringes and non-retractable-safety syringes. In 2012, non-retractable safety syringes that include sheathing tube syringes, syringes with sliding needle covers and hinged needle covers accounted for the larger share in terms of revenue (USD Million) as well as volume (Million Units). However, during the forecast period, the market for retractable safety syringes is expected to grow at a higher CAGR than the non-retractable safety syringes due to increasing safety concerns and adoption in developed regions. The market for retractable safety syringes has been further segmented as automatic retractable safety syringes and manual retractable safety syringes. Automatic retractable safety syringes are more preferred than manual retractable syringes owing to advantage such as ease of use and enhanced safety. The global market for safety syringes is primarily driven by factors such as increasing cases of needlestick injuries and their serious consequences, governmental legislation, overall growth in injectable drugs market and technical advances leading to syringes with improved safety features. According to the U.S. Occupational Safety and Health Administration (OSHA), approximately 5.6 million healthcare workers across the U.S. are high risk of exposure to blood borne diseases via needlestick and other sharp related injuries. The above mentioned fact indicates a favorable growth for safety syringes market. However, the market may face significant challenges from higher cost associated with the safety syringes and continuous development in alternative drug delivery methods. Safety syringes cost two to three times more than the traditional syringes that results in slow adoption rate of safety syringes across the healthcare facilities. This factor is more prominent across the developing nations where healthcare providers believe that the incidence of needlestick injuries can be prevented by providing training to healthcare workers and thus, avoids spending money on purchasing safety syringes. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Safety Syringes Market, by Product Type Chapter 5 Global Safety Syringes Market Revenue, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - Becton, Dickinson & Company - Covidien plc - Retractable Technologies, Inc. - Revolutions Medical Corporation - Smiths Medical - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/d7...y_syringes
Global Hypodermic Needles Market 2014-2018 with Becton, Dickinson and Co, Covidien, Retractable Technologies, Terumo Dominating
M2 - Wed Jun 25, 8:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c7dbr2/global_hypodermic) has announced the addition of the "Global Hypodermic Needles Market 2014-2018" report to their offering. The Global Hypodermic Needles market will grow at a CAGR of 6.66 percent over the period 2013-2018. The Global Hypodermic Needles market is driven by several factors, of which the introduction and enforcement of legislations in various countries for the mandatory use of safety needles is one of the major drivers. Governments worldwide have begun implementing legislation that limits the frequency of actions that often lead to a NSI. With the introduction and enforcement of such legislation, Healthcare and Pharmaceutical markets across the world are now transitioning to the mandatory use of safety needles/syringes to help protect those at risk of infection from NSIs and other unsafe injection practices. These compulsory regulations will have a huge impact and will increase the Global Hypodermic Needles market. According to various legislations, HCWs are required to implement formal written exposure control plans and actively involve frontline HCWs in the selection of safe needle devices. Legislation also requires HCWs to create and maintain sharps injury log books, or to save electronically, which contain detailed information on the type, brand, and manufacturer of devices associated with such injuries. Further, the report states that one of the major challenges faced by the market is the difficulty in the adoption of safety mechanisms by HCWs. The revenue generated in this market can be segmented based on the following types of needle - Manual - Semi-automatic - Automatic/Passive Key Vendors - Becton, Dickinson and Co. - Covidien Ltd. - Retractable Technologies Inc. - Terumo Corp. Other Prominent Vendors - Albert David Ltd. - B-Braun Melsungen AG - Catalent Pharma Solutions - Connectinut Hypodermics Inc. - C.R. Bard - Exel International - Hamilton Syringes & Needles - Hindustan Syringes & Medical Devices Ltd. - Hi-Tech Syringes - MedPro Safety Products - MW Industries Inc. - Needletech Products Inc. - Revolutions Medical Corp. - Safety Medical Supply Intl. - Simply Surgicals LLC - Smiths Medical - Unilife Corp. - Vigmed AB - Vita Needle Co. - Vygon SA Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation By Type - Product Portfolio - Global Non-Safety Needles Market - Global Safety Needles Market - Geographical Segmentation - Key Leading Countries in the Global Hypodermic Needles market - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape For more information visit http://www.researchandmarkets.com/research/c7...hypodermic
Bridge Bancorp, Inc. Announces Regulatory Approvals to Acquire FNBNY Bancorp; FNBNY Shareholder Meeting Date Set
GlobeNewswire - Tue Jan 14, 4:33PM CST
Bridge Bancorp, Inc. (Nasdaq:BDGE), the parent company of The Bridgehampton National Bank (BNB), announced today all regulatory approvals have been received in connection with the acquisition of FNBNY Bancorp and its wholly owned subsidiary, the First National Bank of New York (collectively "FNBNY"
. In addition, FNBNY will hold a special meeting of shareholders on February 12, 2014 to obtain shareholder approval of the acquisition. Shareholders representing a majority of the FNBNY voting shares previously have entered into voting agreements to approve the acquisition, and the transaction is expected to close on Friday, February 14, 2014.
BUYINS.NET Issues Revolutions Medical Corp. SqueezeTrigger Report
M2 - Mon Jul 29, 9:57AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Revolutions Medical Corp (OTC: RMCP) after releasing the latest short sale data through July 26, 2013. The total aggregate number of shares shorted since August 2009 is approximately 31 million shares. Approximately 30.40% of daily trading volume is short selling. The SqueezeTrigger price for all RMCP shares shorted is $0.45. 928,000 shares have been shorted below $0.06 and have already begun squeezing.
$20 Million Awarded in Internet Libel Case
Marketwire - Mon Jul 01, 9:57AM CDT
Revolutions Medical Corporation (OTCQB: RMCP), a Charleston, S.C.-based medical device and software applications company, and its Chief Executive Officer, Rondald Wheet, have been awarded more than $20 million in a default judgment against Phillip Maurice "Marty" Hicks. A special referee for the South Carolina court awarded the company $3.6 million in compensatory damages and $1.5 million in punitive damages. Wheet was awarded $12,010,000 in compensatory damages and $3 million in punitive damages.
Disposable Syringe Markets Report: Comprehensive 2013 Analysis
M2 - Fri Jun 21, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rs2pqx/disposable) has announced the addition of the "Disposable Syringe Markets 2013" report to their offering. The report examines the disposable syringe market. It provides detailed forecasts for the traditional and safety engineered sharps markets. It describes the major drivers and restraints, technology trends, and industry challenges for the disposable syringe market. It examines the markets for blood collection sets, hypodermic access syringes and needles, sharps-based insulin delivery devices, and other specialty syringes and needles. Additionally, the study considers the disposable syringe supplies utilized in clinics and by patients in their homes to diagnose and monitor diseases, as well as to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing g
Revolutions Medical awarded 12m RevVac safety syringes order in Brazil
M2 - Wed May 22, 8:19AM CDT
Medical device company Revolutions Medical Corporation (OTC Markets:RMCP) reported on Tuesday the receipt of a 12m unit contract of its RevVac auto-retractable vacuum safety syringe in Brazil.
Revolutions Medical Receives Contract for 12 Million RevVac(TM) Safety Syringes From Its Brazilian Distributor
Marketwire - Tue May 21, 7:59AM CDT
Revolutions Medical Corporation ("Revolutions Medical" or the "Company" (OTCQB: RMCP) has received a 12 million unit contract of its RevVacâ?¢ auto-retractable vacuum safety syringe from AGN Tech International, LLC, ("AGN Tech" the exclusive distributor of all RevVacâ?¢ safety syringe product lines in Brazil. The contract is for 1 million units per month for a twelve month term.
Revolutions Medical Wins $770,000 Arbitration Award for Fraud and Other Claims Against Former Manufacturer MIG and Former Consultant Richard Theriault
Marketwire - Thu Jan 03, 2:53PM CST
Revolutions Medical Corporation ("Revolutions Medical" or the "Company" (OTCQB: RMCP) has prevailed in its case before the American Arbitration Association (AAA) against former manufacturer Medical Investment Group, Inc. (MIG) and former consultant Richard Theriault. AAA awarded the Company $770,000, in addition to interest, legal fees, and other arbitration costs, which will total close to $1 million dollars. MIG and its alter ego, Mr. Theriault, were found to have committed fraud in the inducement and breach of contract. Further, AAA found that neither MIG nor Mr. Theriault has any rights to any of the Company's intellectual property, proprietary information, trademarks, production equipment or designs related to the issues arbitrated in such proceeding.
Safety Syringes Market - Global Industry Analysis Forecasts to 2019
M2 - Thu Aug 28, 5:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2rsq89/safety_syringes) has announced the addition of the "Safety Syringes Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global market for safety syringes was valued at USD 3,419.1 million in 2012 and is expected to reach USD 6,496.8 million by the end of 2019, growing at a CAGR of 9.7% during the forecast period from 2013 to 2019 Two major types of safety syringes available in the market consist of retractable safety syringes and non-retractable-safety syringes. In 2012, non-retractable safety syringes that include sheathing tube syringes, syringes with sliding needle covers and hinged needle covers accounted for the larger share in terms of revenue (USD Million) as well as volume (Million Units). However, during the forecast period, the market for retractable safety syringes is expected to grow at a higher CAGR than the non-retractable safety syringes due to increasing safety concerns and adoption in developed regions. The market for retractable safety syringes has been further segmented as automatic retractable safety syringes and manual retractable safety syringes. Automatic retractable safety syringes are more preferred than manual retractable syringes owing to advantage such as ease of use and enhanced safety. The global market for safety syringes is primarily driven by factors such as increasing cases of needlestick injuries and their serious consequences, governmental legislation, overall growth in injectable drugs market and technical advances leading to syringes with improved safety features. According to the U.S. Occupational Safety and Health Administration (OSHA), approximately 5.6 million healthcare workers across the U.S. are high risk of exposure to blood borne diseases via needlestick and other sharp related injuries. The above mentioned fact indicates a favorable growth for safety syringes market. However, the market may face significant challenges from higher cost associated with the safety syringes and continuous development in alternative drug delivery methods. Safety syringes cost two to three times more than the traditional syringes that results in slow adoption rate of safety syringes across the healthcare facilities. This factor is more prominent across the developing nations where healthcare providers believe that the incidence of needlestick injuries can be prevented by providing training to healthcare workers and thus, avoids spending money on purchasing safety syringes. Safety Syringes Market, by Product Type - Retractable Safety Syringes - Automatic Retractable Safety Syringes - Manual Retractable Safety Syringes - Non Retractable Safety Syringes Company Profiles - Becton, Dickinson & Company - Covidien plc - Retractable Technologies, Inc. - Revolutions Medical Corporation - Smiths Medical - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/2r...y_syringes
Global Safety Syringes Market 2013-2019: Retractable, Automatic Retractable, Manual Retractable Non-Retractable Safety Syringes
M2 - Tue Jul 22, 2:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d73f6p/safety_syringes) has announced the addition of the "Safety Syringes - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013" report to their offering. The global market for safety syringes was valued at USD 3,419.1 million in 2012 and is expected to reach USD 6,496.8 million by the end of 2019, growing at a CAGR of 9.7% during the forecast period from 2013 to 2019. Two major types of safety syringes available in the market consist of retractable safety syringes and non-retractable-safety syringes. In 2012, non-retractable safety syringes that include sheathing tube syringes, syringes with sliding needle covers and hinged needle covers accounted for the larger share in terms of revenue (USD Million) as well as volume (Million Units). However, during the forecast period, the market for retractable safety syringes is expected to grow at a higher CAGR than the non-retractable safety syringes due to increasing safety concerns and adoption in developed regions. The market for retractable safety syringes has been further segmented as automatic retractable safety syringes and manual retractable safety syringes. Automatic retractable safety syringes are more preferred than manual retractable syringes owing to advantage such as ease of use and enhanced safety. The global market for safety syringes is primarily driven by factors such as increasing cases of needlestick injuries and their serious consequences, governmental legislation, overall growth in injectable drugs market and technical advances leading to syringes with improved safety features. According to the U.S. Occupational Safety and Health Administration (OSHA), approximately 5.6 million healthcare workers across the U.S. are high risk of exposure to blood borne diseases via needlestick and other sharp related injuries. The above mentioned fact indicates a favorable growth for safety syringes market. However, the market may face significant challenges from higher cost associated with the safety syringes and continuous development in alternative drug delivery methods. Safety syringes cost two to three times more than the traditional syringes that results in slow adoption rate of safety syringes across the healthcare facilities. This factor is more prominent across the developing nations where healthcare providers believe that the incidence of needlestick injuries can be prevented by providing training to healthcare workers and thus, avoids spending money on purchasing safety syringes. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Safety Syringes Market, by Product Type Chapter 5 Global Safety Syringes Market Revenue, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - Becton, Dickinson & Company - Covidien plc - Retractable Technologies, Inc. - Revolutions Medical Corporation - Smiths Medical - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/d7...y_syringes
Global Hypodermic Needles Market 2014-2018 with Becton, Dickinson and Co, Covidien, Retractable Technologies, Terumo Dominating
M2 - Wed Jun 25, 8:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c7dbr2/global_hypodermic) has announced the addition of the "Global Hypodermic Needles Market 2014-2018" report to their offering. The Global Hypodermic Needles market will grow at a CAGR of 6.66 percent over the period 2013-2018. The Global Hypodermic Needles market is driven by several factors, of which the introduction and enforcement of legislations in various countries for the mandatory use of safety needles is one of the major drivers. Governments worldwide have begun implementing legislation that limits the frequency of actions that often lead to a NSI. With the introduction and enforcement of such legislation, Healthcare and Pharmaceutical markets across the world are now transitioning to the mandatory use of safety needles/syringes to help protect those at risk of infection from NSIs and other unsafe injection practices. These compulsory regulations will have a huge impact and will increase the Global Hypodermic Needles market. According to various legislations, HCWs are required to implement formal written exposure control plans and actively involve frontline HCWs in the selection of safe needle devices. Legislation also requires HCWs to create and maintain sharps injury log books, or to save electronically, which contain detailed information on the type, brand, and manufacturer of devices associated with such injuries. Further, the report states that one of the major challenges faced by the market is the difficulty in the adoption of safety mechanisms by HCWs. The revenue generated in this market can be segmented based on the following types of needle - Manual - Semi-automatic - Automatic/Passive Key Vendors - Becton, Dickinson and Co. - Covidien Ltd. - Retractable Technologies Inc. - Terumo Corp. Other Prominent Vendors - Albert David Ltd. - B-Braun Melsungen AG - Catalent Pharma Solutions - Connectinut Hypodermics Inc. - C.R. Bard - Exel International - Hamilton Syringes & Needles - Hindustan Syringes & Medical Devices Ltd. - Hi-Tech Syringes - MedPro Safety Products - MW Industries Inc. - Needletech Products Inc. - Revolutions Medical Corp. - Safety Medical Supply Intl. - Simply Surgicals LLC - Smiths Medical - Unilife Corp. - Vigmed AB - Vita Needle Co. - Vygon SA Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation By Type - Product Portfolio - Global Non-Safety Needles Market - Global Safety Needles Market - Geographical Segmentation - Key Leading Countries in the Global Hypodermic Needles market - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape For more information visit http://www.researchandmarkets.com/research/c7...hypodermic
Bridge Bancorp, Inc. Announces Regulatory Approvals to Acquire FNBNY Bancorp; FNBNY Shareholder Meeting Date Set
GlobeNewswire - Tue Jan 14, 4:33PM CST
Bridge Bancorp, Inc. (Nasdaq:BDGE), the parent company of The Bridgehampton National Bank (BNB), announced today all regulatory approvals have been received in connection with the acquisition of FNBNY Bancorp and its wholly owned subsidiary, the First National Bank of New York (collectively "FNBNY"
. In addition, FNBNY will hold a special meeting of shareholders on February 12, 2014 to obtain shareholder approval of the acquisition. Shareholders representing a majority of the FNBNY voting shares previously have entered into voting agreements to approve the acquisition, and the transaction is expected to close on Friday, February 14, 2014. BUYINS.NET Issues Revolutions Medical Corp. SqueezeTrigger Report
M2 - Mon Jul 29, 9:57AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Revolutions Medical Corp (OTC: RMCP) after releasing the latest short sale data through July 26, 2013. The total aggregate number of shares shorted since August 2009 is approximately 31 million shares. Approximately 30.40% of daily trading volume is short selling. The SqueezeTrigger price for all RMCP shares shorted is $0.45. 928,000 shares have been shorted below $0.06 and have already begun squeezing.
$20 Million Awarded in Internet Libel Case
Marketwire - Mon Jul 01, 9:57AM CDT
Revolutions Medical Corporation (OTCQB: RMCP), a Charleston, S.C.-based medical device and software applications company, and its Chief Executive Officer, Rondald Wheet, have been awarded more than $20 million in a default judgment against Phillip Maurice "Marty" Hicks. A special referee for the South Carolina court awarded the company $3.6 million in compensatory damages and $1.5 million in punitive damages. Wheet was awarded $12,010,000 in compensatory damages and $3 million in punitive damages.
Disposable Syringe Markets Report: Comprehensive 2013 Analysis
M2 - Fri Jun 21, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rs2pqx/disposable) has announced the addition of the "Disposable Syringe Markets 2013" report to their offering. The report examines the disposable syringe market. It provides detailed forecasts for the traditional and safety engineered sharps markets. It describes the major drivers and restraints, technology trends, and industry challenges for the disposable syringe market. It examines the markets for blood collection sets, hypodermic access syringes and needles, sharps-based insulin delivery devices, and other specialty syringes and needles. Additionally, the study considers the disposable syringe supplies utilized in clinics and by patients in their homes to diagnose and monitor diseases, as well as to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing g
Revolutions Medical awarded 12m RevVac safety syringes order in Brazil
M2 - Wed May 22, 8:19AM CDT
Medical device company Revolutions Medical Corporation (OTC Markets:RMCP) reported on Tuesday the receipt of a 12m unit contract of its RevVac auto-retractable vacuum safety syringe in Brazil.
Revolutions Medical Receives Contract for 12 Million RevVac(TM) Safety Syringes From Its Brazilian Distributor
Marketwire - Tue May 21, 7:59AM CDT
Revolutions Medical Corporation ("Revolutions Medical" or the "Company"
(OTCQB: RMCP) has received a 12 million unit contract of its RevVacâ?¢ auto-retractable vacuum safety syringe from AGN Tech International, LLC, ("AGN Tech" the exclusive distributor of all RevVacâ?¢ safety syringe product lines in Brazil. The contract is for 1 million units per month for a twelve month term. Revolutions Medical Wins $770,000 Arbitration Award for Fraud and Other Claims Against Former Manufacturer MIG and Former Consultant Richard Theriault
Marketwire - Thu Jan 03, 2:53PM CST
Revolutions Medical Corporation ("Revolutions Medical" or the "Company"
(OTCQB: RMCP) has prevailed in its case before the American Arbitration Association (AAA) against former manufacturer Medical Investment Group, Inc. (MIG) and former consultant Richard Theriault. AAA awarded the Company $770,000, in addition to interest, legal fees, and other arbitration costs, which will total close to $1 million dollars. MIG and its alter ego, Mr. Theriault, were found to have committed fraud in the inducement and breach of contract. Further, AAA found that neither MIG nor Mr. Theriault has any rights to any of the Company's intellectual property, proprietary information, trademarks, production equipment or designs related to the issues arbitrated in such proceeding. 
